BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 37 found
  Current Search:  ser: 37, gen: 184     

HTML
56%
Adenovirus: Study findings from N. Smadja-Lamre et al broaden understanding of adenovirus
Study findings from N.

Smadja-Lamre et al broaden understanding of adenovirus (NewsRx.com) -- Investigators publish new data in the report 'JNK-mediated phosphorylation of paxillin in adhesion assembly and tension-induced cell death by the...

NewsRX:  Jan 7 2009 5:55AM
Matching: ser
Find similar documents
HTML
56%
October to December 2008
BioNewsCast Press Release Service 2006 Archive- January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006 ~ October 2006 ~ November - December 2006 BioNewsCast Press Release ...
BioPortfolio:  Jan 6 2009 10:05AM
Matching: ser
Find similar documents
HTML
56%
The impact of pharmacy-generated recommendations on antibiotic use was assessed, and the antibiotic review ser
_ The impact of pharmacy-generated recommendations on antibiotic use was assessed, and the antibiotic review ser.
Facts & Comparisons:  Jan 5 2009 11:27AM
Matching: ser
Find similar documents
HTML
56%
Method for calibrating antibiotic disk diffusion testing of microorganisms
Title: United States Patent: 7,465,559 Inventors: Kronvall; Goran (Taby, SE) Assignee: Bioscand AB (Taby, SE) Appl.

No.: 10/474,488 Filed: April 8, 2002 PCT Filed: April 08, 2002 PCT No.: PCT/SE02/00688 371(c)(1),(2),(4) Date: April 19,...

PharmCast:  Jan 1 2009 4:45AM
Matching: ser
Find similar documents
HTML
56%
Role of the Ser-287-Asn Replacement in the Hydrolysis Spectrum Extension of AmpC -Lactamases in Escherichia c
Antimicrobial Agents and Chemotherapy, January 2009, p.

323-326, Vol.

53, No.

1 Copyright 2009, American Society for Microbiology.

All Rights Reserved.

Role of the Ser-287-Asn Replacement in the Hydrolysis Spectrum Extension...

AAC:  Dec 26 2008 11:06AM
Matching: ser
Find similar documents
HTML
56%
Europe and Mercosur to support biotech research
La biotecnologa se aplicar en salud bovina, entre otras reas Kersti Nebelsiek | Wikipedia La Unin Europea y el Mercosur anunciaron que dedicarn tres millones de euros a cinco proyectos de investigacin y desarrollo (I+D) en biotecnologa.

En...

SciDev.net:  Dec 26 2008 6:25PM
Matching: ser
Find similar documents
HTML
56%
Reports outline apoptosis study results from Allergan, Inc
(NewsRx.com) -- New research, 'Integrities of A/B and C domains of RXR are required for rexinoid-induced caspase activations and apoptosis,' is the subject of a report.

'Here we have delineated regions of the retinoid X receptor alpha ...

NewsRX:  Dec 22 2008 2:55PM
Matching: ser
Find similar documents
HTML
56%
Risk of prostate cancer unaffected by antibiotic treatment
MedWire News: Although serum total prostate-specific antigen (PSA) levels are decreased by antibiotic therapy, the risk for prostate cancer is not reduced, warn Turkish investigators.

Some urologists prescribe antibiotics before biopsy for...

MedWire News:  Dec 17 2008 7:02PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland The multinational study analyzed a number of SNPs that had been suggestively linked with fasting glucose levels in several major studies involving some 36,000 individuals from Europe 'This finding is another step towards...
Genetic Engineering News:  Dec 9 2008 11:12PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the...

KOTA Territory News:  Dec 8 2008 8:21PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the...

KSLA:  Dec 8 2008 8:03PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the...

Montana's News Station:  Dec 8 2008 6:39PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the...

KLFY:  Dec 8 2008 3:54PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN - News) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single...

PR Newswire via Yahoo!:  Dec 8 2008 3:49PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, December 8 /PRNewswire/ -- deCODE genetics (News) (Nasdaq: DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter...
FinanzNachrichten.de:  Dec 8 2008 2:55PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter...

Street Insider:  Dec 8 2008 2:52PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter...

Biz Journals:  Dec 8 2008 2:46PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter...

Cincinnati Business Journal:  Dec 8 2008 2:46PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter...

Portland Business Journal:  Dec 8 2008 2:45PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN - News) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single...

Yahoo! Canada:  Dec 8 2008 2:42PM
Matching: ser
Find similar documents
HTML
56%
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Ser
REYKJAVIK, Iceland, Dec.

8 /PRNewswire-FirstCall/ -- deCODE genetics (DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation...

Houston Chronicle:  Dec 8 2008 2:36PM
Matching: ser
Find similar documents
HTML
56%
Polymorphisms associated with tardive dyskinesia in schizophrenia
MedWire News: Tardive dyskinesia in schizophrenia patients is associated with polymorphisms in the quinine oxidoreductase (NQO1) and manganese superoxide dismutase (MnSOD) genes, South Korean study findings indicate.

It has been suggested...

MedWire News:  Dec 8 2008 12:54AM
Matching: ser
Find similar documents
HTML
56%
Treatment of gestational diabetes
Pharmaceutical Patents Title: United States Patent: 7,452,858 Issued: November 18, 2008 Hiles; Richard A.

(San Diego, CA), Prickett; Kathryn S.

(San Diego, CA) Amylin Pharmaceuticals, Inc.

(San Diego, CA) Appl.

No.: November 17, 2005...

PharmCast:  Dec 5 2008 4:58AM
Matching: ser
Find similar documents
HTML
56%
Use of ADNF polypeptides for treating peripheral neurotoxicity
Pharmaceutical Patents Title: United States Patent: 7,452,867 Issued: November 18, 2008 Gozes; Illana (Ramat-Hasharon, IL), Miller; James (Vancouver, CA) Ramot at Tel-Aviv University, Ltd.

(Tel Aviv, IL) Appl.

No.: March 23, 2006 This...

PharmCast:  Dec 3 2008 1:01PM
Matching: ser
Find similar documents
HTML
56%
Fitch Rates NC Medical Care Commission Rev Bonds (FirstHealth of Carolinas Proj) Ser 08A&B 'AA/F1+'
Fitch Ratings affirms the 'AA' long-term rating and assigns an 'F1+' short-term rating to the $106,845,000 North Carolina Medical Care Commission, variable rate demand health care facilities revenue refunding bonds (FirstHealth of the...
Genetic Engineering News:  Dec 1 2008 11:34PM
Matching: ser
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.